ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Daridorexant Hydrochloride Tablets Market Research Report 2025
Published Date: November 2025
|
Report Code: QYRE-Auto-31P19998
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Daridorexant Hydrochloride Tablets Market Research Report 2025
BUY CHAPTERS

Global Daridorexant Hydrochloride Tablets Market Research Report 2025

Code: QYRE-Auto-31P19998
Report
November 2025
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Idorsia Ltd
Simcere Pharmaceutical
Nxera Pharma

Daridorexant Hydrochloride Tablets Market Size

The global market for Daridorexant Hydrochloride Tablets was valued at US$ 69.19 million in the year 2024 and is projected to reach a revised size of US$ 831 million by 2031, growing at a CAGR of 29.8% during the forecast period.

Daridorexant Hydrochloride Tablets Market

Daridorexant Hydrochloride Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Daridorexant Hydrochloride Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Daridorexant Hydrochloride Tablets, marketed under the brand name Quviviq, is an innovative medication for the treatment of insomnia. As a dual orexin receptor antagonist (DORA) targeting both OX1 and OX2 receptors, Daridorexant helps regulate the sleep–wake cycle to improve both sleep onset and maintenance. Unlike benzodiazepines or Z-drugs, it does not act on GABA receptors, thereby reducing the risks of tolerance and dependence associated with traditional hypnotics. Administered orally, Daridorexant has a relatively short elimination half-life of approximately 8 hours, with peak plasma concentrations reached 1–2 hours post-dose. Common adverse effects include headache, somnolence, and fatigue. The U.S. FDA approved Daridorexant (25 mg and 50 mg) in January 2022 for the treatment of adult insomnia, followed by its U.S. launch in May 2022. Subsequent approvals and launches occurred across Europe, Canada, Japan, and other regions, making it the first EMA-approved DORA shown to improve both nighttime sleep and daytime functioning. In 2024, global sales reached 3.94 million tablets, with an average price of USD 17.56 per tablet and a gross margin of 71.2%, underscoring its strong clinical value and commercial performance worldwide.
In the U.S. and Europe, Daridorexant has entered a phase of rapid commercial expansion, supported by favorable clinical differentiation and growing physician adoption. Within the European Union, it is the most recent DORA approved by the EMA for improving both nighttime sleep and daytime functioning—an indication that broadens its clinical appeal beyond sleep onset and maintenance alone. Compared with other DORAs, its pharmacokinetic profile and well-balanced efficacy-safety ratio contribute to higher treatment adherence and positive real-world outcomes.
From a commercial standpoint, Daridorexant’s global rollout reflects a strategic blend of licensing, distribution, and market access initiatives. Regional partnerships enable efficient regulatory navigation and localized market penetration, ensuring coverage across hospitals, retail pharmacies, and online prescription platforms. Reimbursement listings in select countries further enhance patient accessibility, reinforcing uptake momentum. The integration of pharmacovigilance and patient-reported outcomes into post-marketing surveillance also supports sustained physician confidence and long-term safety validation.
Market uptake has been strongest in North America, Western Europe, and Japan, where supportive healthcare infrastructure and awareness campaigns accelerate adoption. In emerging markets such as China, Daridorexant’s entry underscores the expanding recognition of DORA-based therapeutics as the next-generation standard for insomnia care. Continued emphasis on education, real-world data generation, and stable supply chains will be critical to maintaining its growth trajectory.
Overall, Daridorexant exemplifies the evolution of insomnia therapeutics toward mechanism-driven, safety-conscious innovation. Its combination of differentiated pharmacology, robust clinical data, and strategic commercialization positions it as a leading agent in the global sleep medicine landscape—poised to define the post-benzodiazepine era of pharmacological sleep management.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Daridorexant Hydrochloride Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daridorexant Hydrochloride Tablets.
The Daridorexant Hydrochloride Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Daridorexant Hydrochloride Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, by Dosage Form and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daridorexant Hydrochloride Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, by Dosage Form and by regions.

Scope of Daridorexant Hydrochloride Tablets Market Report

Report Metric Details
Report Name Daridorexant Hydrochloride Tablets Market
Accounted market size in year US$ 69.19 million
Forecasted market size in 2031 US$ 831 million
CAGR 29.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 25mg
  • 50 mg
Segment by Dosage Form
  • Tablets
  • Other
Segment by Research Attributes
  • Original Drug
  • Generic Drug
Segment by Application
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Idorsia, Simcere Pharmaceutical, Nxera Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Daridorexant Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Daridorexant Hydrochloride Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Daridorexant Hydrochloride Tablets Market growing?

Ans: The Daridorexant Hydrochloride Tablets Market witnessing a CAGR of 29.8% during the forecast period 2025-2031.

What is the Daridorexant Hydrochloride Tablets Market size in 2031?

Ans: The Daridorexant Hydrochloride Tablets Market size in 2031 will be US$ 831 million.

Who are the main players in the Daridorexant Hydrochloride Tablets Market report?

Ans: The main players in the Daridorexant Hydrochloride Tablets Market are Idorsia, Simcere Pharmaceutical, Nxera Pharma

What are the Application segmentation covered in the Daridorexant Hydrochloride Tablets Market report?

Ans: The Applications covered in the Daridorexant Hydrochloride Tablets Market report are Hospital and Clinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Daridorexant Hydrochloride Tablets Market report?

Ans: The Types covered in the Daridorexant Hydrochloride Tablets Market report are 25mg, 50 mg

1 Daridorexant Hydrochloride Tablets Market Overview
1.1 Product Definition
1.2 Daridorexant Hydrochloride Tablets by Type
1.2.1 Global Daridorexant Hydrochloride Tablets Market Value Comparison by Type (2024 VS 2031)
1.2.2 25mg
1.2.3 50 mg
1.3 Daridorexant Hydrochloride Tablets by Dosage Form
1.3.1 Global Daridorexant Hydrochloride Tablets Market Value Comparison by Dosage Form: 2024 VS 2031
1.3.2 Tablets
1.3.3 Other
1.4 Daridorexant Hydrochloride Tablets by Research Attributes
1.4.1 Global Daridorexant Hydrochloride Tablets Market Value Comparison by Research Attributes: 2024 VS 2031
1.4.2 Original Drug
1.4.3 Generic Drug
1.5 Daridorexant Hydrochloride Tablets by Application
1.5.1 Global Daridorexant Hydrochloride Tablets Market Value by Application (2024 VS 2031)
1.5.2 Hospital and Clinic
1.5.3 Retail Pharmacies
1.5.4 Other
1.6 Global Daridorexant Hydrochloride Tablets Market Size Estimates and Forecasts
1.6.1 Global Daridorexant Hydrochloride Tablets Revenue 2020-2031
1.6.2 Global Daridorexant Hydrochloride Tablets Sales 2020-2031
1.6.3 Global Daridorexant Hydrochloride Tablets Market Average Price (2020-2031)
1.7 Assumptions and Limitations
2 Daridorexant Hydrochloride Tablets Market Competition by Manufacturers
2.1 Global Daridorexant Hydrochloride Tablets Sales Market Share by Manufacturers (2020-2025)
2.2 Global Daridorexant Hydrochloride Tablets Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Daridorexant Hydrochloride Tablets Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Daridorexant Hydrochloride Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daridorexant Hydrochloride Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daridorexant Hydrochloride Tablets, Product Type & Application
2.7 Global Key Manufacturers of Daridorexant Hydrochloride Tablets, Date of Enter into This Industry
2.8 Global Daridorexant Hydrochloride Tablets Market Competitive Situation and Trends
2.8.1 Global Daridorexant Hydrochloride Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Daridorexant Hydrochloride Tablets Players Market Share by Revenue
2.8.3 Global Daridorexant Hydrochloride Tablets Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Daridorexant Hydrochloride Tablets Market Scenario by Region
3.1 Global Daridorexant Hydrochloride Tablets Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Daridorexant Hydrochloride Tablets Sales by Region: 2020-2031
3.2.1 Global Daridorexant Hydrochloride Tablets Sales by Region: 2020-2025
3.2.2 Global Daridorexant Hydrochloride Tablets Sales by Region: 2026-2031
3.3 Global Daridorexant Hydrochloride Tablets Revenue by Region: 2020-2031
3.3.1 Global Daridorexant Hydrochloride Tablets Revenue by Region: 2020-2025
3.3.2 Global Daridorexant Hydrochloride Tablets Revenue by Region: 2026-2031
3.4 North America Daridorexant Hydrochloride Tablets Market Facts & Figures by Country
3.4.1 North America Daridorexant Hydrochloride Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Daridorexant Hydrochloride Tablets Sales by Country (2020-2031)
3.4.3 North America Daridorexant Hydrochloride Tablets Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Daridorexant Hydrochloride Tablets Market Facts & Figures by Country
3.5.1 Europe Daridorexant Hydrochloride Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Daridorexant Hydrochloride Tablets Sales by Country (2020-2031)
3.5.3 Europe Daridorexant Hydrochloride Tablets Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daridorexant Hydrochloride Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Daridorexant Hydrochloride Tablets Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Daridorexant Hydrochloride Tablets Sales by Region (2020-2031)
3.6.3 Asia Pacific Daridorexant Hydrochloride Tablets Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Daridorexant Hydrochloride Tablets Market Facts & Figures by Country
3.7.1 Latin America Daridorexant Hydrochloride Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Daridorexant Hydrochloride Tablets Sales by Country (2020-2031)
3.7.3 Latin America Daridorexant Hydrochloride Tablets Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Daridorexant Hydrochloride Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Daridorexant Hydrochloride Tablets Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Daridorexant Hydrochloride Tablets Sales by Country (2020-2031)
3.8.3 Middle East and Africa Daridorexant Hydrochloride Tablets Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daridorexant Hydrochloride Tablets Sales by Type (2020-2031)
4.1.1 Global Daridorexant Hydrochloride Tablets Sales by Type (2020-2025)
4.1.2 Global Daridorexant Hydrochloride Tablets Sales by Type (2026-2031)
4.1.3 Global Daridorexant Hydrochloride Tablets Sales Market Share by Type (2020-2031)
4.2 Global Daridorexant Hydrochloride Tablets Revenue by Type (2020-2031)
4.2.1 Global Daridorexant Hydrochloride Tablets Revenue by Type (2020-2025)
4.2.2 Global Daridorexant Hydrochloride Tablets Revenue by Type (2026-2031)
4.2.3 Global Daridorexant Hydrochloride Tablets Revenue Market Share by Type (2020-2031)
4.3 Global Daridorexant Hydrochloride Tablets Price by Type (2020-2031)
5 Segment by Application
5.1 Global Daridorexant Hydrochloride Tablets Sales by Application (2020-2031)
5.1.1 Global Daridorexant Hydrochloride Tablets Sales by Application (2020-2025)
5.1.2 Global Daridorexant Hydrochloride Tablets Sales by Application (2026-2031)
5.1.3 Global Daridorexant Hydrochloride Tablets Sales Market Share by Application (2020-2031)
5.2 Global Daridorexant Hydrochloride Tablets Revenue by Application (2020-2031)
5.2.1 Global Daridorexant Hydrochloride Tablets Revenue by Application (2020-2025)
5.2.2 Global Daridorexant Hydrochloride Tablets Revenue by Application (2026-2031)
5.2.3 Global Daridorexant Hydrochloride Tablets Revenue Market Share by Application (2020-2031)
5.3 Global Daridorexant Hydrochloride Tablets Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Idorsia
6.1.1 Idorsia Company Information
6.1.2 Idorsia Description and Business Overview
6.1.3 Idorsia Daridorexant Hydrochloride Tablets Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Idorsia Daridorexant Hydrochloride Tablets Product Portfolio
6.1.5 Idorsia Recent Developments/Updates
6.2 Simcere Pharmaceutical
6.2.1 Simcere Pharmaceutical Company Information
6.2.2 Simcere Pharmaceutical Description and Business Overview
6.2.3 Simcere Pharmaceutical Daridorexant Hydrochloride Tablets Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Simcere Pharmaceutical Daridorexant Hydrochloride Tablets Product Portfolio
6.2.5 Simcere Pharmaceutical Recent Developments/Updates
6.3 Nxera Pharma
6.3.1 Nxera Pharma Company Information
6.3.2 Nxera Pharma Description and Business Overview
6.3.3 Nxera Pharma Daridorexant Hydrochloride Tablets Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nxera Pharma Daridorexant Hydrochloride Tablets Product Portfolio
6.3.5 Nxera Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daridorexant Hydrochloride Tablets Industry Chain Analysis
7.2 Daridorexant Hydrochloride Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daridorexant Hydrochloride Tablets Production Mode & Process Analysis
7.4 Daridorexant Hydrochloride Tablets Sales and Marketing
7.4.1 Daridorexant Hydrochloride Tablets Sales Channels
7.4.2 Daridorexant Hydrochloride Tablets Distributors
7.5 Daridorexant Hydrochloride Tablets Customer Analysis
8 Daridorexant Hydrochloride Tablets Market Dynamics
8.1 Daridorexant Hydrochloride Tablets Industry Trends
8.2 Daridorexant Hydrochloride Tablets Market Drivers
8.3 Daridorexant Hydrochloride Tablets Market Challenges
8.4 Daridorexant Hydrochloride Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Idorsia Ltd
Simcere Pharmaceutical
Nxera Pharma
List of Tables
 Table 1. Global Daridorexant Hydrochloride Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Daridorexant Hydrochloride Tablets Market Value by Dosage Form, (US$ Million) & (2024 VS 2031)
 Table 3. Global Daridorexant Hydrochloride Tablets Market Value by Research Attributes, (US$ Million) & (2024 VS 2031)
 Table 4. Global Daridorexant Hydrochloride Tablets Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 5. Global Daridorexant Hydrochloride Tablets Market Competitive Situation by Manufacturers in 2024
 Table 6. Global Daridorexant Hydrochloride Tablets Sales (K Units) of Key Manufacturers (2020-2025)
 Table 7. Global Daridorexant Hydrochloride Tablets Sales Market Share by Manufacturers (2020-2025)
 Table 8. Global Daridorexant Hydrochloride Tablets Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 9. Global Daridorexant Hydrochloride Tablets Revenue Share by Manufacturers (2020-2025)
 Table 10. Global Market Daridorexant Hydrochloride Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 11. Global Key Players of Daridorexant Hydrochloride Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 12. Global Key Manufacturers of Daridorexant Hydrochloride Tablets, Manufacturing Sites & Headquarters
 Table 13. Global Key Manufacturers of Daridorexant Hydrochloride Tablets, Product Type & Application
 Table 14. Global Key Manufacturers of Daridorexant Hydrochloride Tablets, Date of Enter into This Industry
 Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 16. Global Daridorexant Hydrochloride Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daridorexant Hydrochloride Tablets as of 2024)
 Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 18. Global Daridorexant Hydrochloride Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 19. Global Daridorexant Hydrochloride Tablets Sales by Region (2020-2025) & (K Units)
 Table 20. Global Daridorexant Hydrochloride Tablets Sales Market Share by Region (2020-2025)
 Table 21. Global Daridorexant Hydrochloride Tablets Sales by Region (2026-2031) & (K Units)
 Table 22. Global Daridorexant Hydrochloride Tablets Sales Market Share by Region (2026-2031)
 Table 23. Global Daridorexant Hydrochloride Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 24. Global Daridorexant Hydrochloride Tablets Revenue Market Share by Region (2020-2025)
 Table 25. Global Daridorexant Hydrochloride Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 26. Global Daridorexant Hydrochloride Tablets Revenue Market Share by Region (2026-2031)
 Table 27. North America Daridorexant Hydrochloride Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 28. North America Daridorexant Hydrochloride Tablets Sales by Country (2020-2025) & (K Units)
 Table 29. North America Daridorexant Hydrochloride Tablets Sales by Country (2026-2031) & (K Units)
 Table 30. North America Daridorexant Hydrochloride Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 31. North America Daridorexant Hydrochloride Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 32. Europe Daridorexant Hydrochloride Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 33. Europe Daridorexant Hydrochloride Tablets Sales by Country (2020-2025) & (K Units)
 Table 34. Europe Daridorexant Hydrochloride Tablets Sales by Country (2026-2031) & (K Units)
 Table 35. Europe Daridorexant Hydrochloride Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 36. Europe Daridorexant Hydrochloride Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 37. Asia Pacific Daridorexant Hydrochloride Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 38. Asia Pacific Daridorexant Hydrochloride Tablets Sales by Region (2020-2025) & (K Units)
 Table 39. Asia Pacific Daridorexant Hydrochloride Tablets Sales by Region (2026-2031) & (K Units)
 Table 40. Asia Pacific Daridorexant Hydrochloride Tablets Revenue by Region (2020-2025) & (US$ Million)
 Table 41. Asia Pacific Daridorexant Hydrochloride Tablets Revenue by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Daridorexant Hydrochloride Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Latin America Daridorexant Hydrochloride Tablets Sales by Country (2020-2025) & (K Units)
 Table 44. Latin America Daridorexant Hydrochloride Tablets Sales by Country (2026-2031) & (K Units)
 Table 45. Latin America Daridorexant Hydrochloride Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Daridorexant Hydrochloride Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 47. Middle East and Africa Daridorexant Hydrochloride Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 48. Middle East and Africa Daridorexant Hydrochloride Tablets Sales by Country (2020-2025) & (K Units)
 Table 49. Middle East and Africa Daridorexant Hydrochloride Tablets Sales by Country (2026-2031) & (K Units)
 Table 50. Middle East and Africa Daridorexant Hydrochloride Tablets Revenue by Country (2020-2025) & (US$ Million)
 Table 51. Middle East and Africa Daridorexant Hydrochloride Tablets Revenue by Country (2026-2031) & (US$ Million)
 Table 52. Global Daridorexant Hydrochloride Tablets Sales (K Units) by Type (2020-2025)
 Table 53. Global Daridorexant Hydrochloride Tablets Sales (K Units) by Type (2026-2031)
 Table 54. Global Daridorexant Hydrochloride Tablets Sales Market Share by Type (2020-2025)
 Table 55. Global Daridorexant Hydrochloride Tablets Sales Market Share by Type (2026-2031)
 Table 56. Global Daridorexant Hydrochloride Tablets Revenue (US$ Million) by Type (2020-2025)
 Table 57. Global Daridorexant Hydrochloride Tablets Revenue (US$ Million) by Type (2026-2031)
 Table 58. Global Daridorexant Hydrochloride Tablets Revenue Market Share by Type (2020-2025)
 Table 59. Global Daridorexant Hydrochloride Tablets Revenue Market Share by Type (2026-2031)
 Table 60. Global Daridorexant Hydrochloride Tablets Price (US$/Unit) by Type (2020-2025)
 Table 61. Global Daridorexant Hydrochloride Tablets Price (US$/Unit) by Type (2026-2031)
 Table 62. Global Daridorexant Hydrochloride Tablets Sales (K Units) by Application (2020-2025)
 Table 63. Global Daridorexant Hydrochloride Tablets Sales (K Units) by Application (2026-2031)
 Table 64. Global Daridorexant Hydrochloride Tablets Sales Market Share by Application (2020-2025)
 Table 65. Global Daridorexant Hydrochloride Tablets Sales Market Share by Application (2026-2031)
 Table 66. Global Daridorexant Hydrochloride Tablets Revenue (US$ Million) by Application (2020-2025)
 Table 67. Global Daridorexant Hydrochloride Tablets Revenue (US$ Million) by Application (2026-2031)
 Table 68. Global Daridorexant Hydrochloride Tablets Revenue Market Share by Application (2020-2025)
 Table 69. Global Daridorexant Hydrochloride Tablets Revenue Market Share by Application (2026-2031)
 Table 70. Global Daridorexant Hydrochloride Tablets Price (US$/Unit) by Application (2020-2025)
 Table 71. Global Daridorexant Hydrochloride Tablets Price (US$/Unit) by Application (2026-2031)
 Table 72. Idorsia Company Information
 Table 73. Idorsia Description and Business Overview
 Table 74. Idorsia Daridorexant Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 75. Idorsia Daridorexant Hydrochloride Tablets Product
 Table 76. Idorsia Recent Developments/Updates
 Table 77. Simcere Pharmaceutical Company Information
 Table 78. Simcere Pharmaceutical Description and Business Overview
 Table 79. Simcere Pharmaceutical Daridorexant Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 80. Simcere Pharmaceutical Daridorexant Hydrochloride Tablets Product
 Table 81. Simcere Pharmaceutical Recent Developments/Updates
 Table 82. Nxera Pharma Company Information
 Table 83. Nxera Pharma Description and Business Overview
 Table 84. Nxera Pharma Daridorexant Hydrochloride Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 85. Nxera Pharma Daridorexant Hydrochloride Tablets Product
 Table 86. Nxera Pharma Recent Developments/Updates
 Table 87. Key Raw Materials Lists
 Table 88. Raw Materials Key Suppliers Lists
 Table 89. Daridorexant Hydrochloride Tablets Distributors List
 Table 90. Daridorexant Hydrochloride Tablets Customers List
 Table 91. Daridorexant Hydrochloride Tablets Market Trends
 Table 92. Daridorexant Hydrochloride Tablets Market Drivers
 Table 93. Daridorexant Hydrochloride Tablets Market Challenges
 Table 94. Daridorexant Hydrochloride Tablets Market Restraints
 Table 95. Research Programs/Design for This Report
 Table 96. Key Data Information from Secondary Sources
 Table 97. Key Data Information from Primary Sources
 Table 98. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Daridorexant Hydrochloride Tablets
 Figure 2. Global Daridorexant Hydrochloride Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Daridorexant Hydrochloride Tablets Market Share by Type: 2024 & 2031
 Figure 4. 25mg Product Picture
 Figure 5. 50 mg Product Picture
 Figure 6. Global Daridorexant Hydrochloride Tablets Market Value by Dosage Form, (US$ Million) & (2020-2031)
 Figure 7. Global Daridorexant Hydrochloride Tablets Market Share by Dosage Form: 2024 VS 2031
 Figure 8. Tablets Product Picture
 Figure 9. Other Product Picture
 Figure 10. Global Daridorexant Hydrochloride Tablets Market Value by Research Attributes, (US$ Million) & (2020-2031)
 Figure 11. Global Daridorexant Hydrochloride Tablets Market Share by Research Attributes: 2024 VS 2031
 Figure 12. Original Drug Product Picture
 Figure 13. Generic Drug Product Picture
 Figure 14. Global Daridorexant Hydrochloride Tablets Market Value by Application (2020-2031) & (US$ Million)
 Figure 15. Global Daridorexant Hydrochloride Tablets Market Share by Application: 2024 & 2031
 Figure 16. Hospital and Clinic
 Figure 17. Retail Pharmacies
 Figure 18. Other
 Figure 19. Global Daridorexant Hydrochloride Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Daridorexant Hydrochloride Tablets Market Size (2020-2031) & (US$ Million)
 Figure 21. Global Daridorexant Hydrochloride Tablets Sales (2020-2031) & (K Units)
 Figure 22. Global Daridorexant Hydrochloride Tablets Average Price (US$/Unit) & (2020-2031)
 Figure 23. Daridorexant Hydrochloride Tablets Report Years Considered
 Figure 24. Daridorexant Hydrochloride Tablets Sales Share by Manufacturers in 2024
 Figure 25. Global Daridorexant Hydrochloride Tablets Revenue Share by Manufacturers in 2024
 Figure 26. Global 5 and 10 Largest Daridorexant Hydrochloride Tablets Players: Market Share by Revenue in Daridorexant Hydrochloride Tablets in 2024
 Figure 27. Daridorexant Hydrochloride Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 28. Global Daridorexant Hydrochloride Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 29. North America Daridorexant Hydrochloride Tablets Sales Market Share by Country (2020-2031)
 Figure 30. North America Daridorexant Hydrochloride Tablets Revenue Market Share by Country (2020-2031)
 Figure 31. United States Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Canada Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Europe Daridorexant Hydrochloride Tablets Sales Market Share by Country (2020-2031)
 Figure 34. Europe Daridorexant Hydrochloride Tablets Revenue Market Share by Country (2020-2031)
 Figure 35. Germany Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. France Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. U.K. Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Italy Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Russia Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Asia Pacific Daridorexant Hydrochloride Tablets Sales Market Share by Region (2020-2031)
 Figure 41. Asia Pacific Daridorexant Hydrochloride Tablets Revenue Market Share by Region (2020-2031)
 Figure 42. China Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Japan Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. South Korea Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. India Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Australia Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. China Taiwan Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Southeast Asia Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Latin America Daridorexant Hydrochloride Tablets Sales Market Share by Country (2020-2031)
 Figure 50. Latin America Daridorexant Hydrochloride Tablets Revenue Market Share by Country (2020-2031)
 Figure 51. Mexico Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Brazil Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Argentina Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Colombia Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Daridorexant Hydrochloride Tablets Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Daridorexant Hydrochloride Tablets Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. UAE Daridorexant Hydrochloride Tablets Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Daridorexant Hydrochloride Tablets by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Daridorexant Hydrochloride Tablets by Type (2020-2031)
 Figure 62. Global Daridorexant Hydrochloride Tablets Price (US$/Unit) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Daridorexant Hydrochloride Tablets by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Daridorexant Hydrochloride Tablets by Application (2020-2031)
 Figure 65. Global Daridorexant Hydrochloride Tablets Price (US$/Unit) by Application (2020-2031)
 Figure 66. Daridorexant Hydrochloride Tablets Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Plant Derived Analgesics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35P19891
Fri Nov 14 00:00:00 UTC 2025

Add to Cart

Global Sarpogrelate Hydrochloride Tablets Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-33A16793
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Itraconazole Oral Solution Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-29T16753
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Global Anti-inflammatory Agents Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-10U17234
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions